Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

LyondellBasell's (LYB) Q4 Earnings & Revenues Lag Estimates

Published 01/31/2019, 11:55 PM
Updated 07/09/2023, 06:31 AM

LyondellBasell Industries N.V.’s (NYSE:LYB) posted net profits of $692 million or $1.79 per share in fourth-quarter 2018, down from $1,894 million or $4.79 in the year-ago quarter.

Barring one-time items (acquisition related costs), adjusted earnings came in at $1.83 per share, which missed the Zacks Consensus Estimate of $2.13.

LyondellBasell recorded revenues of $8,876 million, down roughly 2.8% year over year. The figure also trailed the consensus mark of $9,222 million.

Consolidated EBITDA declined around 29.8% year over year to $1,212 million.

Per the company, results in the quarter were affected by a decline in crude oil prices along with unusual operational events and challenges in the refining market.

2018 Highlights

In 2018, revenues jumped 13.1% year over year to $39,004 million. Net earnings came in at $4,690 million or $12.01 per share, down from $4,877 million or $12.23 in the prior-year quarter.

Segment Review

In the Olefins & Polyolefins — Americas division, EBITDA fell around 17.9% year over year to $631 million. Olefin results declined by roughly $55 million year over year due to a fall in ethylene prices. Polyolefins results dropped around $65 million, mainly due to declines in polyethylene volume and margin.

The Olefins & Polyolefins — Europe, Asia, International segment witnessed a decline in EBITDA of around 56.1% year over year to $127 million. Olefin results fell roughly $70 million on a year-over-year basis. Per the company, volume declined due to unplanned and planned maintenance at its cracker in Wesseling, Germany as well as low Rhine River levels. Consolidated polyolefins results declined around $90 million.
The Advanced Polymer Solutions (APS) segment saw a rise in EBITDA to $86 million from $82 million in the year-ago quarter. The addition of new product lines from the A. Schulman acquisition were partly offset by margin and volume declines in polypropylene compounds.

EBITDA in the Intermediates and Derivatives segment went down around 7.6% on a year-over-year basis to $379 million. Propylene Oxide & Derivatives results were affected by lower volumes stemming from planned maintenance.

EBITDA in the Refining segment declined $188 million year over year. The company’s Houston Refinery operated at 184,000 barrels per day during the quarter, down by 61,000 barrels per day from the prior-year quarter’s level. The downside was caused by planned maintenance during the fourth quarter.

The Technology segment’s EBITDA fell year over year to $61 million from $68 million, mainly due to decline in licensing revenues.

Financials

As of Dec 31, 2018, LyondellBasell had cash and liquid investments of $1.8 billion.

The company paid out dividend and repurchased 11.5 million shares during the quarter, totaling $1.4 billion in the fourth quarter and $3.4 billion in 2018.

Outlook

LyondellBasell witnessed normalization of markets with higher polymer demand and modest improvements in the discount for Maya crude oil during the first few weeks of 2019. The company expects growth to accelerate this year, courtesy of the planned startup of its Hyperzone polyethylene facility and construction of the new PO/TBA plant.

Per the company, global polyethylene capacity additions are likely to be moderate in 2019 and 2020. This is expected to provide support for high industry operating rates and ethylene chain profitability.

Price Performance

Shares of LyondellBasell lost around 20.2% in the past three months compared with the industry’s decline of 18.3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Zacks Rank & Key Picks

LyondellBasell currently carries a Zacks Rank #4 (Sell).

A few better-ranked stocks in the basic materials space include Ingevity Corporation (NYSE:NGVT) , Quaker Chemical Corporation (NYSE:KWR) and Israel Chemicals Ltd (NYSE:ICL) . While Ingevity and Israel Chemicals sport a Zacks Rank #1 (Strong Buy), Quaker Chemical carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Ingevity has an expected earnings growth rate of 21.5% for 2019. The company’s shares have gained 29.5% in the past year.

Israel Chemicals has an expected earnings growth rate of 5.4% for 2019. Its shares have rallied 40.2% in a year’s time.

Quaker Chemical has an expected earnings growth rate of 21.1% for 2019. Its shares have surged 35.5% in a year’s time.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



LyondellBasell Industries N.V. (LYB): Free Stock Analysis Report

Israel Chemicals Shs (ICL): Free Stock Analysis Report

Quaker Chemical Corporation (KWR): Free Stock Analysis Report

Ingevity Corporation (NGVT): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.